Tianjin Pharmaceutical da Ren Tang Group Ltd 2018 Annual Report
Company: Tianjin Pharmaceutical da Ren Tang Group Ltd
Sector: Manufacturing
Country: China
Year: 2018
Type: Annual Report
Pages: 172
The report describes 2018 revenue of 6,358,622 RMB'000 and continued growth in pharmaceutical operations. It highlights research on 20 new products, expanded quality management, and six industrial enterprises passing GMP certification. The company also reports 133 official staff employed during the year and continued investment in talent development. Its sustainability reporting identifies energy, water, emissions, effluents and waste, occupational health and safety, and diversity as key topics, with a Sustainability task force overseeing reporting.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.